Commercial therapeutic protein drug products

  • Brian K. Meyer*
  • , Mohammed Shameem
  • *Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

7 Scopus citations

Abstract

Commercially available therapeutic proteins are formulated as both liquid and lyophilized products. The most common buffer utilized is phosphate, followed by histidine, citrate, acetate, tris, and others. Excipients that are most frequently utilized are sodium chloride, sucrose, and the non-ionic detergents polysorbate 20 and 80. The most common containers utilized are vials followed by pre-filled syringes. These marketed therapeutic protein drug products formulations may be used as a reference point during the development of future products.

Original languageEnglish
Title of host publicationTherapeutic Protein Drug Products
Subtitle of host publicationPractical Approaches to formulation in the Laboratory, Manufacturing, and the Clinic
PublisherElsevier Ltd.
Pages1-11
Number of pages11
ISBN (Print)9781907568183
DOIs
StatePublished - Jan 2012
Externally publishedYes

Keywords

  • Administration
  • Buffer
  • Commercial
  • Container
  • Excipients
  • Formulation
  • Liquid
  • Lyophilized
  • Protein
  • Salt
  • Sugar
  • Therapeutic

ASJC Scopus subject areas

  • General Dentistry
  • General Medicine

Fingerprint

Dive into the research topics of 'Commercial therapeutic protein drug products'. Together they form a unique fingerprint.

Cite this